MedTrace Logo

A Study of Idazoxan in Healthy Participants

NCT05727189 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-03-18

No results posted yet for this study

Summary

Four-part study of the safety, tolerability and pharmacokinetics of 3 forms of TR-01-XRR, 1 form of TR-01-XRS, and 1 form of TR-01-XR in healthy adults.

Conditions

  • Healthy

Interventions

DRUG

TR-01-XRR (1)

Extended-release form

DRUG

TR-01-XRR (2)

Extended-release form

DRUG

TR-01-XRR (3)

Extended-release form

DRUG

TR-01-XRS

Extended-release form

DRUG

TR-01-XR

Extended-release form

DRUG

TR-01-IR

Active comparator

DRUG

Placebo

Placebo comparator

Sponsors & Collaborators

  • Terran Biosciences Australia Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Robert Fishman, MD · Clinical Lead Consultant

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05727189 on ClinicalTrials.gov